Advanced Medical Solutions Grp PLC Management Change (7746L)

TIDMAMS

RNS Number : 7746L

Advanced Medical Solutions Grp PLC

31 December 2018

 
   31 December 2018

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Board Change

Winsford, UK, 31 December 2018: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, today announces with immediate effect the retirement of Mary Tavener from the role of Chief Financial Officer and Board Director, and confirms the appointment of Eddie Johnson, previously Group Financial Controller, as Chief Financial Officer and Board Director, with effect from 1 January 2019, per the Company's announcement dated 6 June 2018.

There have been no changes to the disclosures regarding Mr Johnson, as set out in the announcement of 6 June 2018.

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group plc                    Tel: +44 (0) 1606 
                                                                    545508 
 Chris Meredith, Chief Executive Officer 
 
 Consilium Strategic Communications                   Tel: +44 (0) 20 3709 
                                                                      5700 
 Mary-Jane Elliott / Matthew Neal / Nicholas       AMS@consilium-comms.com 
  Brown / Olivia Manser 
 
 Investec Bank PLC (NOMAD & Broker)                   Tel: +44 (0) 20 7597 
                                                                      5970 
 Daniel Adams / Gary Clarence / Patrick 
  Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BOAWGGRUPUPRGMU

(END) Dow Jones Newswires

December 31, 2018 02:00 ET (07:00 GMT)

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024